Glomed OÜ

12343461

Company info

Glomed OÜ

12343461

Likvideerimismenetlus - Likvideerimis- Ja Pankrotimenetlushttps://likvideerimismenetlus.eeLikvideerimismenetlus - Likvideerimis- Ja Pankrotimenetlus

Likvideerimismenetlus OÜ tegeleb likvideerimis ja pankrotimenetlusega. Pakume abi probleemsete firmade müügi ja nende likvideerimisega.

General info

Name

Glomed OÜ

Registry code

12343461

Type

OÜ - Limited Liability Company

Status

In liquidation

Foundation date

10.09.2012 (12)

Financial year

01.01-31.12

Capital

2 500.00 €

Activity

46191 - Agents involved in the sale of a variety of goods

Revenue

-

Profit

-

Profit margin

-

Gross salary

-

Equity

-

Employees

-

Annual report

Not submitted

Tax arrears

No tax arrears

Return on equity

-

Return on assets

-

Related parties

Owner Representative Beneficial owner Roles

Ryan James Lechelt

06.05.1990 (34)

10% - 250.00 EUR - Direct ownership

Likvideerimismenetlus OÜ

12273275

90% - 2 250.00 EUR - -

Ingmar Pärn

14.06.1974 (50)

- Liquidator Other control or influence (contractual, family or other relationships)

Peeter Mander

15.05.1987 (37)

- - - Founder

Related companies

Owner Representative Beneficial owner Roles

at-visions Nordic OÜ

14818247

1% - 100.00 EUR - -

EPIC Coffee Roastery OÜ

16001935

- - - Founder

Financial info

2019
23.03.2022
2020
12.05.2022
2021
03.01.2023
Total Revenue 1 500 € 29 312 € 39 000 €
Net profit (loss) for the period 1 200 € 3 583 € 2 517 €
Profit Margin 80% 12% 6%
Current Assets 1 200 € 4 783 € 6 100 €
Fixed Assets 0 € 0 € 0 €
Total Assets 1 200 € 4 783 € 6 100 €
Current Liabilities - - 0 €
Non Current Liabilities 0 € 0 € 0 €
Total Liabilities - - -
Share Capital - - -
Equity 1 200 € 4 783 € 6 100 €
Employees 0 0 0

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2023 Q3 - 10 € - -
2023 Q2 - 55.98 € - -
2023 Q1 3 434.5 € 79.02 € - -
2022 Q4 1 827.5 € 805.58 € - -
2022 Q3 724 € 110.16 € - -
2022 Q2 39 988.2 € - - -
2022 Q1 31 656.2 € 4 737.39 € - -
2021 Q4 1 170 € 194 € - -
2021 Q3 - - - -